Extremophilic Fungi from Marine Environments: Underexplored Sources of Antitumor, Anti-Infective and Other Biologically Active Agents
Open Access
- 10 January 2022
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 20 (1) , 62
Abstract
Marine environments are underexplored terrains containing fungi that produce a diversity of natural products given unique environmental pressures and nutrients. While bacteria are commonly the most studied microorganism for natural products in the marine world, marine fungi are also abundant but remain an untapped source of bioactive metabolites. Given that their terrestrial counterparts have been a source of many blockbuster antitumor agents and anti-infectives, including camptothecin, the penicillins, and cyclosporin A, marine fungi also have the potential to produce new chemical scaffolds as leads to potential drugs. Fungi are more phylogenetically diverse than bacteria and have larger genomes that contain many silent biosynthetic gene clusters involved in making bioactive compounds. However, less than 5% of all known fungi have been cultivated under standard laboratory conditions. While the number of reported natural products from marine fungi is steadily increasing, their number is still significantly lower compared to those reported from their bacterial counterparts. Herein, we discuss many varied cytotoxic and anti-infective fungal metabolites isolated from extreme marine environments, including symbiotic associations as well as extreme pressures, temperatures, salinity, and light. We also discuss cultivation strategies that can be used to produce new bioactive metabolites or increase their production. This review presents a large number of reported structures though, at times, only a few of a large number of related structures are shown.Keywords
This publication has 150 references indexed in Scilit:
- Two Novel Hepatocellular Carcinoma Cycle Inhibitory Cyclodepsipeptides from a Hydrothermal Vent Crab-Associated Fungus Aspergillus clavatus C2WUMarine Drugs, 2013
- Examining the Fish Microbiome: Vertebrate-Derived Bacteria as an Environmental Niche for the Discovery of Unique Marine Natural ProductsPLOS ONE, 2012
- A Sterol and Spiroditerpenoids from a Penicillium sp. Isolated from a Deep Sea Sediment SampleMarine Drugs, 2012
- Evidence for a core gut microbiota in the zebrafishThe ISME Journal, 2011
- Effects of High Salt Stress on Secondary Metabolite Production in the Marine-Derived Fungus Spicaria elegansMarine Drugs, 2011
- SZ‐685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathwayBritish Journal of Pharmacology, 2010
- Intimate bacterial–fungal interaction triggers biosynthesis of archetypal polyketides inAspergillus nidulansProceedings of the National Academy of Sciences, 2009
- New Azaphilones, Seco-Chaetomugilins A and D, Produced by a Marine-Fish-Derived Chaetomium globosumMarine Drugs, 2009
- Molecular Genetic Mining of the Aspergillus Secondary Metabolome: Discovery of the Emericellamide Biosynthetic PathwayChemistry & Biology, 2008
- Histone Deacetylase Activity Regulates Chemical Diversity in AspergillusEukaryotic Cell, 2007